Invention Grant
US08926957B2 Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
有权
在皮肤淋巴细胞抗原阳性T细胞介导的疾病中使用IL-31拮抗剂的方法
- Patent Title: Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
- Patent Title (中): 在皮肤淋巴细胞抗原阳性T细胞介导的疾病中使用IL-31拮抗剂的方法
-
Application No.: US13799048Application Date: 2013-03-13
-
Publication No.: US08926957B2Publication Date: 2015-01-06
- Inventor: Janine Bilsborough , Jane A. Gross
- Applicant: ZymoGenetics, Inc.
- Applicant Address: US WA Seattle
- Assignee: ZymoGenetics, Inc.
- Current Assignee: ZymoGenetics, Inc.
- Current Assignee Address: US WA Seattle
- Agent Brian J. Walsh
- Main IPC: A61K45/00
- IPC: A61K45/00 ; A61K39/00 ; G01N33/68 ; A61K49/00 ; C07K14/52 ; C07K16/24 ; C07K16/28 ; G01N33/50 ; A61K39/395
Abstract:
The present invention relates to predicting therapeutic response of treating patients suffering from itching and pruritis mediated by cutaneous lymphocyte antigen positive T cells in atopic dermatitis. The invention also includes methods of predicting a therapeutically responsive patient population.
Public/Granted literature
- US20130203070A1 METHODS OF USING IL-31 ANTAGONISTS IN DISEASES MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE T CELLS Public/Granted day:2013-08-08
Information query
